Isolation of Bone Cells and Biomolecules from Human Surgical Bone Waste

Overview

About this study

The purpose of this study is to obtain bone from up to 200 patients undergoing orthopedic procedures (including elective hip replacement or hip replacement following fracture) to perform these studies. From these waste bone samples that would otherwise be discarded following review by pathology, we will isolate bone cells (osteoblasts, osteoclast, and osteocytes), protein, RNA, and DNA.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Will vary according to the condition we are currently studying

Exclusion Criteria:

Will vary according to the condition we are currently studying

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Sundeep Khosla, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Louise McCready R.N. (507)284-4329 mccready.louise@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sundeep Khosla, M.D.

Closed-enrolling by invitation

Contact information:

Louise McCready R.N.

(507)284-4329

mccready.louise@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials